BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 38227150)

  • 1. The emerging roles of histone demethylases in cancers.
    Tong D; Tang Y; Zhong P
    Cancer Metastasis Rev; 2024 Jun; 43(2):795-821. PubMed ID: 38227150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of histone demethylases in cancer therapy.
    Hoffmann I; Roatsch M; Schmitt ML; Carlino L; Pippel M; Sippl W; Jung M
    Mol Oncol; 2012 Dec; 6(6):683-703. PubMed ID: 22902149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone demethylases set the stage for cancer metastasis.
    Cao J; Yan Q
    Sci Signal; 2013 Apr; 6(273):pe15, 1-2. PubMed ID: 23633674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone lysine demethylases as targets for anticancer therapy.
    Højfeldt JW; Agger K; Helin K
    Nat Rev Drug Discov; 2013 Dec; 12(12):917-30. PubMed ID: 24232376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting histone lysine demethylases - progress, challenges, and the future.
    Thinnes CC; England KS; Kawamura A; Chowdhury R; Schofield CJ; Hopkinson RJ
    Biochim Biophys Acta; 2014 Dec; 1839(12):1416-32. PubMed ID: 24859458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future therapeutic potential of histone demethylases: A critical analysis.
    Natoli G; Testa G; De Santa F
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting histone demethylases in cancer therapy.
    Grant S
    Clin Cancer Res; 2009 Dec; 15(23):7111-3. PubMed ID: 19934292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
    Liu K; Liu Y; Lau JL; Min J
    Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Tsai CT; So CW
    Oncogene; 2017 Mar; 36(13):1753-1759. PubMed ID: 27593928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.
    Tian X; Zhang S; Liu HM; Zhang YB; Blair CA; Mercola D; Sassone-Corsi P; Zi X
    Curr Cancer Drug Targets; 2013 Jun; 13(5):558-79. PubMed ID: 23713993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
    Simó-Riudalbas L; Esteller M
    Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Lysine Demethylase Inhibitors.
    Jambhekar A; Anastas JN; Shi Y
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 28049654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.
    Gelato KA; Adler D; Ocker M; Haendler B
    Expert Opin Ther Targets; 2016 Jul; 20(7):783-99. PubMed ID: 26799480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic agents in combined anticancer therapy.
    Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V
    Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Histone Methylation in Cancer.
    McCabe MT; Mohammad HP; Barbash O; Kruger RG
    Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting histone demethylases as a potential cancer therapy (Review).
    Diao W; Zheng J; Li Y; Wang J; Xu S
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35801593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.